DOI QR코드

DOI QR Code

Genetic Profiles of Korean Patients With Glucose-6-Phosphate Dehydrogenase Deficiency

  • Lee, Jaewoong (Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea) ;
  • Park, Joonhong (Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea) ;
  • Choi, Hayoung (Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea) ;
  • Kim, Jiyeon (Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea) ;
  • Kwon, Ahlm (Catholic Genetic Laboratory Center, College of Medicine, The Catholic University of Korea) ;
  • Jang, Woori (Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea) ;
  • Chae, Hyojin (Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kim, Myungshin (Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea) ;
  • Kim, Yonggoo (Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea) ;
  • Lee, Jae Wook (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Chung, Nack-Gyun (Department of Pediatrics, College of Medicine, The Catholic University of Korea) ;
  • Cho, Bin (Department of Pediatrics, College of Medicine, The Catholic University of Korea)
  • Received : 2016.04.07
  • Accepted : 2016.11.29
  • Published : 2017.03.01

Abstract

Background: We describe the genetic profiles of Korean patients with glucose-6-phosphate dehydrogenase (G6PD) deficiencies and the effects of G6PD mutations on protein stability and enzyme activity on the basis of in silico analysis. Methods: In parallel with a genetic analysis, the pathogenicity of G6PD mutations detected in Korean patients was predicted in silico. The simulated effects of G6PD mutations were compared to the WHO classes based on G6PD enzyme activity. Four previously reported mutations and three newly diagnosed patients with missense mutations were estimated. Results: One novel mutation (p.Cys385Gly, labeled G6PD Kangnam) and two known mutations [p.Ile220Met (G6PD $S{\tilde{a}}o$ Paulo) and p.Glu416Lys (G6PD Tokyo)] were identified in this study. G6PD mutations identified in Koreans were also found in Brazil (G6PD $S{\tilde{a}}o$ Paulo), Poland (G6PD Seoul), United States of America (G6PD Riley), Mexico (G6PD Guadalajara), and Japan (G6PD Tokyo). Several mutations occurred at the same nucleotide, but resulted in different amino acid residue changes in different ethnic populations (p.Ile380 variant, G6PD Calvo Mackenna; p.Cys385 variants, Tomah, Madrid, Lynwood; p.Arg387 variant, Beverly Hills; p.Pro396 variant, Bari; and p.Pro396Ala in India). On the basis of the in silico analysis, Class I or II mutations were predicted to be highly deleterious, and the effects of one Class IV mutation were equivocal. Conclusions: The genetic profiles of Korean individuals with G6PD mutations indicated that the same mutations may have arisen by independent mutational events, and were not derived from shared ancestral mutations. The in silico analysis provided insight into the role of G6PD mutations in enzyme function and stability.

Keywords

Acknowledgement

Supported by : Ministry of Health & Welfare

References

  1. Cappellini MD and Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008;371:64-74. https://doi.org/10.1016/S0140-6736(08)60073-2
  2. Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ 1989;67:601-11.
  3. Park SW, Lee HJ, Lee W, Whang KT. A Case of Glucose-6-phosphate dehydrogenase Riley Causing Hemolytic Anemia. Korean J Hematol 1999; 34:334-7.
  4. Lee GB, Lee SJ, Kim YJ, Kim SY, Kim HH, Cho B, et al. A Case of G-6-PD Guadalajara. Korean J Pediatr 2004;47:210-3.
  5. Beutler E and Vulliamy TJ. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis 2002;28:93-103. https://doi.org/10.1006/bcmd.2002.0490
  6. Jang M-A, Kim J-Y, Lee K-O, Kim S-H, Koo HH, Kim H-J. A Novel de novo Mutation in the G6PD Gene in a Korean Boy with Glucose-6-phosphate Dehydrogenase Deficiency: Case Report. Ann Clin Lab Sci 2015; 45:446-8.
  7. Stenson P, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 2014;133:1-9. https://doi.org/10.1007/s00439-013-1358-4
  8. Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res 2014;42:D980-5. https://doi.org/10.1093/nar/gkt1113
  9. Xue Y, Chen Y, Ayub Q, Huang N, Ball EV, Mort M, et al. Deleterious- and Disease-Allele Prevalence in Healthy Individuals: Insights from Current Predictions, Mutation Databases, and Population-Scale Resequencing. American Journal of Human Genetics 2012;91:1022-32. https://doi.org/10.1016/j.ajhg.2012.10.015
  10. Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res 2012;40:W452-7. https://doi.org/10.1093/nar/gks539
  11. Choi Y and Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics 2015; 31:2745-7. https://doi.org/10.1093/bioinformatics/btv195
  12. Stone EA and Sidow A. Physicochemical constraint violation by missense substitutions mediates impairment of protein function and disease severity. Genome Res 2005;15:978-86. https://doi.org/10.1101/gr.3804205
  13. Tavtigian SV, Byrnes GB, Goldgar DE, Thomas A. Classification of rare missense substitutions, using risk surfaces, with genetic-and molecular-epidemiology applications. Hum Mutat 2008;29:1342-54. https://doi.org/10.1002/humu.20896
  14. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-9. https://doi.org/10.1038/nmeth0410-248
  15. Li B, Krishnan VG, Mort ME, Xin F, Kamati KK, Cooper DN, et al. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 2009;25:2744-50. https://doi.org/10.1093/bioinformatics/btp528
  16. De Baets G, Van Durme J, Reumers J, Maurer-Stroh S, Vanhee P, Dopazo J, et al. SNPeffect 4.0: on-line prediction of molecular and structural effects of protein-coding variants. Nucleic Acids Res 2012;40:D935-9. https://doi.org/10.1093/nar/gkr996
  17. Valdar WS. Scoring residue conservation. Proteins 2002;48:227-41. https://doi.org/10.1002/prot.10146
  18. Oliveira RA, Oshiro M, Hirata MH, Hirata RD, Ribeiro GS, Medeiros TM, et al. A novel point mutation in a class IV glucose-6-phosphate dehydrogenase variant (G6PD Sao Paulo) and polymorphic G6PD variants in Sao Paulo State, Brazil. Genet Mol Biol 2009;32:251-4. https://doi.org/10.1590/S1415-47572009005000033
  19. Hirono A, Fujii H, Hirono K, Kanno H, Miwa S. Molecular abnormality of a Japanese glucose-6-phosphate dehydrogenase variant (G6PD Tokyo) associated with hereditary non-spherocytic hemolytic anemia. Hum Genet 1992;88:347-8.
  20. Beutler E, Westwood B, Prchal J, Vaca G, Bartsocas CS, Baronciani L. New glucose-6-phosphate dehydrogenase mutations from various ethnic groups. Blood 1992;80:255-6. https://doi.org/10.1182/blood.V80.1.255.255
  21. Beutler E, Westwood B, Melemed A, Dal Borgo P, Margolis D. Three new exon 10 glucose-6-phosphate dehydrogenase mutations. Blood Cells Mol Dis 1995;21:64-72. https://doi.org/10.1006/bcmd.1995.0010
  22. Hirono A, Kuhl W, Gelbart T, Forman L, Fairbanks VF, Beutler E. Identification of the binding domain for NADP+ of human glucose-6-phosphate dehydrogenase by sequence analysis of mutants. Proc Natl Acad Sci U S A 1989;86:10015-7. https://doi.org/10.1073/pnas.86.24.10015
  23. Zarza R, Pujades A, Rovira A, Saavedra R, Fernandez J, Aymerich M, et al. Two new mutations of the glucose-6-phospate dehydrogenase (G6PD) gene associated with haemolytic anaemia: clinical, biochemical and molecular relationships. Br J Haematol 1997;98:578-82. https://doi.org/10.1046/j.1365-2141.1997.2563071.x
  24. Bulliamy T, Luzzatto L, Hirono A, Beutler E. Hematologically important mutations: glucose-6-phosphate dehydrogenase. Blood Cells Mol Dis 1997;23:302-13. https://doi.org/10.1006/bcmd.1997.0147
  25. Minucci A, Moradkhani K, Hwang MJ, Zuppi C, Giardina B, Capoluongo E. Glucose-6-phosphate dehydrogenase (G6PD) mutations database: review of the “old” and update of the new mutations. Blood Cells Mol Dis 2012;48:154-65. https://doi.org/10.1016/j.bcmd.2012.01.001
  26. Kaczorowska-Hac B, Burzynska B, Plochocka D, Zak-Jasinska K, Rawa K, Adamkiewicz-Drozynska E. The first reported case of G6PD deficiency due to Seoul mutation in Poland. Ann Hematol 2014;93:879-80. https://doi.org/10.1007/s00277-013-1899-6
  27. Edison ES, Melinkeri SR, Chandy M. A novel missense mutation in glucose-6-phosphate dehydrogenase gene causing chronic nonspherocytic hemolytic anemia in an Indian family. Ann Hematol 2006;85:879-80. https://doi.org/10.1007/s00277-006-0156-7
  28. Filosa S, Cai W, Galanello R, Cao A, De Mattia D, Schettini F, et al. A novel single-base mutation in the glucose 6-phosphate dehydrogenase gene is associated with chronic non-spherocytic haemolytic anaemia. Hum Genet 1994;94:560-2. https://doi.org/10.1007/BF00211027
  29. Mason PJ, Bautista JM, Gilsanz F. G6PD deficiency: the genotype-phenotype association. Blood Rev 2007;21:267-83. https://doi.org/10.1016/j.blre.2007.05.002
  30. Weimer TA, Salzano FM, Westwood B, Beutler E. Molecular characterization of glucose-6-phosphate dehydrogenase variants from Brazil. Hum Biol 1993:41-7.
  31. Sukumar S, Mukherjee MB, Colah RB, Mohanty D. Molecular characterization of G6PD Insuli-a novel 989 CGC $\rightarrow$ CAC (330 Arg $\rightarrow$ His) mutation in the Indian population. Blood Cells Mol Dis 2003;30:246-7. https://doi.org/10.1016/S1079-9796(03)00018-4
  32. Vaca G, Arambula E, Monsalvo A, Medina C, Nunez C, Sandoval L, et al. Glucose-6-phosphate dehydrogenase (G-6-PD) mutations in Mexico: four new G-6-PD variants. Blood Cells Mol Dis 2003;31:112-20. https://doi.org/10.1016/S1079-9796(03)00119-0

Cited by

  1. Diagnostic approaches for inherited hemolytic anemia in the genetic era vol.52, pp.2, 2017, https://doi.org/10.5045/br.2017.52.2.84
  2. Analysis of Glucose-6-Phosphate Dehydrogenase Genetic Polymorphism in the Hakka Population in Southern China vol.24, pp.None, 2018, https://doi.org/10.12659/msm.908402
  3. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries vol.12, pp.4, 2018, https://doi.org/10.1371/journal.pntd.0006230
  4. Newborn screening of glucose-6-phosphate dehydrogenase deficiency in Guangxi, China: determination of optimal cutoff value to identify heterozygous female neonates vol.8, pp.None, 2017, https://doi.org/10.1038/s41598-017-17667-6
  5. Challenges and Considerations in Sequence Variant Interpretation for Mendelian Disorders vol.39, pp.5, 2017, https://doi.org/10.3343/alm.2019.39.5.421
  6. A novel G6PD deleterious variant identified in three families with severe glucose-6-phosphate dehydrogenase deficiency vol.21, pp.None, 2017, https://doi.org/10.1186/s12881-020-01090-2
  7. Investigation of glucose-6-phosphate dehydrogenase (G6PD) deficiency prevalence in a Plasmodium vivax -endemic area in the Republic of Korea (ROK) vol.19, pp.1, 2020, https://doi.org/10.1186/s12936-020-03393-4
  8. G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs vol.12, pp.None, 2017, https://doi.org/10.3389/fphar.2021.638885
  9. A Profile of Glucose-6-Phosphate Dehydrogenase Variants and Deficiency of Multicultural Families in Korea vol.59, pp.5, 2017, https://doi.org/10.3347/kjp.2021.59.5.447
  10. A Profile of Glucose-6-Phosphate Dehydrogenase Variants and Deficiency of Multicultural Families in Korea vol.59, pp.5, 2017, https://doi.org/10.3347/kjp.2021.59.5.447